If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Jaypirca ® (pirtobrutinib) tablets
50 mg,100 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
VIDEO: What is the efficacy and safety of Jaypirca™ (pirtobrutinib) in patients with MCL who have received prior BTK-inhibitor treatment?
Date of Last Review: April 27, 2024
Document Number: VV-MED-158365